Inhibidor de la recaptación de serotonina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibidor de la recaptación de serotonina" in Spanish language version.

refsWebsite

Global rank Spanish rank

9nih.gov

4^th place

9doi.org

2^nd place

1books.google.com

3^rd place

7^th place

1archive.org

6^th place

5^th place

1zenodo.org

621^st place

862^nd place

1uspto.gov

1,459^th place

1,201^st place

1web.archive.org

1^st place

1pat2pdf.org

low place

archive.org

Gillman PK (2005). «Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity». Br J Anaesth 95 (4): 434-41. PMID 16051647. doi:10.1093/bja/aei210.

books.google.com

Gerald P. Koocher; John C. Norcross; Beverly A. Greene (2013). Psychologists' Desk Reference. Oxford University Press. pp. 442-. ISBN 978-0-19-984550-7.

doi.org

dx.doi.org

Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). «Pharmacological profile of antidepressants and related compounds at human monoamine transporters». Eur. J. Pharmacol. 340 (2–3): 249-58. PMID 9537821. doi:10.1016/s0014-2999(97)01393-9.
Owens MJ, Knight DL, Nemeroff CB (2001). «Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine». Biol Psychiatry 50 (5): 345-50. PMID 11543737. doi:10.1016/s0006-3223(01)01145-3.
Deardorff WJ, Grossberg GT (2014). «A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine». Expert Opin Pharmacother 15 (17): 2525-42. PMID 25224953. doi:10.1517/14656566.2014.960842.
Gründer G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I (2011). «Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging». Pharmacopsychiatry 44 (6): 236-48. PMID 21959785. doi:10.1055/s-0031-1286282.
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R (2009). «Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram». Int Clin Psychopharmacol 24 (3): 119-25. PMID 19367152. doi:10.1097/YIC.0b013e32832a8ec8.
Werling LL; Keller A; Frank JG; Nuwayhid SJ (2007). «A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder». Exp. Neurol. 207 (2): 248-57. PMID 17689532. doi:10.1016/j.expneurol.2007.06.013.
Gillman PK (2005). «Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity». Br J Anaesth 95 (4): 434-41. PMID 16051647. doi:10.1093/bja/aei210.
Yeh SY; Dersch C; Rothman R; Cadet JL (September 1999). «Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats». Synapse 33 (3): 207-17. PMID 10420168. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8.
Li C, Shan L, Li X, Wei L, Li D (2014). «Mifepristone modulates serotonin transporter function». Neural Regen Res 9 (6): 646-52. PMC 4146234. PMID 25206868. doi:10.4103/1673-5374.130112.

nih.gov

ncbi.nlm.nih.gov

Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). «Pharmacological profile of antidepressants and related compounds at human monoamine transporters». Eur. J. Pharmacol. 340 (2–3): 249-58. PMID 9537821. doi:10.1016/s0014-2999(97)01393-9.
Owens MJ, Knight DL, Nemeroff CB (2001). «Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine». Biol Psychiatry 50 (5): 345-50. PMID 11543737. doi:10.1016/s0006-3223(01)01145-3.
Deardorff WJ, Grossberg GT (2014). «A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine». Expert Opin Pharmacother 15 (17): 2525-42. PMID 25224953. doi:10.1517/14656566.2014.960842.
Gründer G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I (2011). «Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging». Pharmacopsychiatry 44 (6): 236-48. PMID 21959785. doi:10.1055/s-0031-1286282.
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R (2009). «Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram». Int Clin Psychopharmacol 24 (3): 119-25. PMID 19367152. doi:10.1097/YIC.0b013e32832a8ec8.
Werling LL; Keller A; Frank JG; Nuwayhid SJ (2007). «A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder». Exp. Neurol. 207 (2): 248-57. PMID 17689532. doi:10.1016/j.expneurol.2007.06.013.
Gillman PK (2005). «Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity». Br J Anaesth 95 (4): 434-41. PMID 16051647. doi:10.1093/bja/aei210.
Yeh SY; Dersch C; Rothman R; Cadet JL (September 1999). «Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats». Synapse 33 (3): 207-17. PMID 10420168. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8.
Li C, Shan L, Li X, Wei L, Li D (2014). «Mifepristone modulates serotonin transporter function». Neural Regen Res 9 (6): 646-52. PMC 4146234. PMID 25206868. doi:10.4103/1673-5374.130112.

pat2pdf.org

Pharmaceutical compositions containing mesembrine and related compounds. U.S. Patent 6,288,104 Archivado el 21 de agosto de 2017 en Wayback Machine. (PDF)

uspto.gov

patft.uspto.gov

Pharmaceutical compositions containing mesembrine and related compounds. U.S. Patent 6,288,104 Archivado el 21 de agosto de 2017 en Wayback Machine. (PDF)

web.archive.org

Pharmaceutical compositions containing mesembrine and related compounds. U.S. Patent 6,288,104 Archivado el 21 de agosto de 2017 en Wayback Machine. (PDF)

zenodo.org

Yeh SY; Dersch C; Rothman R; Cadet JL (September 1999). «Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats». Synapse 33 (3): 207-17. PMID 10420168. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8.